Viyash Scientific Limited intimates exchanges of a scheduled analyst/investor conference call on May 20, 2026.
The call, mandated under SEBI LODR Reg. 30, will discuss the company's Q4 FY26 financial results.
Key management including the MD & Group CEO, Animal Health CEO, and CFO will be presenting.